These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 36706246)

  • 1. Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.
    Rohokale R; Guo Z
    ACS Infect Dis; 2023 Feb; 9(2):178-212. PubMed ID: 36706246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria.
    Snapper CM
    Vaccine; 2016 Jun; 34(30):3542-8. PubMed ID: 27133879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic carbohydrate-based vaccines: challenges and opportunities.
    Mettu R; Chen CY; Wu CY
    J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
    Adamo R
    Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan Microarrays Containing Synthetic Streptococcus pneumoniae CPS Fragments and Their Application to Vaccine Development.
    Kaplonek P; Seeberger PH
    Methods Mol Biol; 2022; 2460():193-206. PubMed ID: 34972938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new vaccine concept: polysaccharide conjugate vaccines].
    Moreau M
    Ann Pharm Fr; 1999 May; 57(3):223-31. PubMed ID: 10427857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
    Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-cell depolymerization of polysaccharide antigens. Exploring the processing pathways of glycans and why some glycoconjugate vaccines are less effective than expected: A review.
    Koj S; Lugowski C; Niedziela T
    Carbohydr Polym; 2023 Sep; 315():120969. PubMed ID: 37230635
    [No Abstract]   [Full Text] [Related]  

  • 9. The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.
    Mond JJ; Kokai-Kun JF
    Curr Top Microbiol Immunol; 2008; 319():17-40. PubMed ID: 18080413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving vaccines against
    Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
    Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
    ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate-protein conjugate vaccines.
    Ada G; Isaacs D
    Clin Microbiol Infect; 2003 Feb; 9(2):79-85. PubMed ID: 12588327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in lipopolysaccharide-based glycoconjugate vaccines.
    Zhu H; Rollier CS; Pollard AJ
    Expert Rev Vaccines; 2021 Dec; 20(12):1515-1538. PubMed ID: 34550840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further approaches for optimizing polysaccharide-protein conjugate vaccines for prevention of invasive bacterial disease.
    Jennings H
    J Infect Dis; 1992 Jun; 165 Suppl 1():S156-9. PubMed ID: 1588152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].
    Mulard L
    Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Holme K; Jennings HJ; Wessels MR
    J Biol Chem; 1990 Oct; 265(30):18278-83. PubMed ID: 2120228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
    Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
    Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
    Jakobsen H; Jonsdottir I
    Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.